haloperidol has been researched along with Carcinoma, Hepatocellular in 4 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to evaluate the anti-tumor effect of curcumin (C) in combination with F2 (N-n-butyl haloperidol iodide) on hepatocellular carcinoma and its potential underlying mechanism in vitro and in vivo." | 8.02 | Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling. ( Chen, L; Feng, H; Huang, D; Khan, H; Ni, Z; Niu, Y; Shi, G; Wu, X; Xing, Y, 2021) |
| "This study aimed to evaluate the anti-tumor effect of curcumin (C) in combination with F2 (N-n-butyl haloperidol iodide) on hepatocellular carcinoma and its potential underlying mechanism in vitro and in vivo." | 4.02 | Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling. ( Chen, L; Feng, H; Huang, D; Khan, H; Ni, Z; Niu, Y; Shi, G; Wu, X; Xing, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, H | 1 |
| Ni, Z | 1 |
| Feng, H | 1 |
| Xing, Y | 1 |
| Wu, X | 1 |
| Huang, D | 1 |
| Chen, L | 1 |
| Niu, Y | 1 |
| Shi, G | 1 |
| Bai, T | 1 |
| Wang, S | 1 |
| Zhao, Y | 1 |
| Zhu, R | 1 |
| Wang, W | 1 |
| Sun, Y | 1 |
| Wolf, CF | 1 |
| Munkelt, BE | 1 |
| Schoental, R | 1 |
4 other studies available for haloperidol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Curcumin; Enhancer of Zest | 2021 |
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Haloperidol; | 2017 |
Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries.
Topics: Acrylic Resins; Animals; Artificial Organs; Aspartate Aminotransferases; Bilirubin; Capillaries; Car | 1975 |
Carcinogenic and chronic effects of 4,4'-diaminodiphenylmethane, an epoxyresin hardener.
Topics: Aniline Compounds; Animals; Carcinogens; Carcinoma, Hepatocellular; Epoxy Resins; Hemangioma; Kidney | 1968 |